C. Has

Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy

D. Castiglia, D. Rafei-Shamsabadi, M. Saleva, 2024, Cancers.

Combined anti‐inflammatory and low‐dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa

C. Has, A. Reimer, L. Bruckner-Tuderman, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Phenotypic spectrum of epidermolysis bullosa associated with α6β4 integrin mutations

A. Sieron, C. Has, J. Kohlhase, 2013, The British journal of dermatology.

a including phenotype with abnormal anchoring and

A. Kariminejad, S. Zeinali, H. Vahidnezhad, 2018 .

and deep phenotyping remains a crucial factor that dictates successful diagnosis of EB

A. Reimer, A. Zimmer, J. Küsel, 2022 .

Epidermolysis Bullosa

J. McGrath, I. Chapple, C. Has, 2020, Braun-Falco´s Dermatology.